Mirati’s First KRAS Data Look At Least As Good As Amgen’s

 
• By Mandy Jackson
  
SC1910_Tree-lungs_246277042_1200.jpg
KRAS G12C mutations are found in 14% of non-small cell lung cancer tumors • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D